Združene države Amerike - angleščina - NLM (National Library of Medicine)

piramal healthcare uk limited - cisatracurium besylate (unii: 80ys8o1mbs) (cisatracurium - unii:qx62kli41n) - cisatracurium besylate injection, usp is indicated:        •as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age        •to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the icu        •to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older limitations of use cisatracurium besylate injection, usp is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. cisatracurium besylate injection, usp is contraindicated in patients with known hypersensitivity to cisatracurium. severe anaphylactic reactions to cisatracurium besylate injection, usp have been reported [see warnings and precautions (5.4 )] . the use of 10 ml cisatracurium besylate injection, usp multiple-dose vials is contraindicated for use in pediatric patients less than 1 month of age and low birth w

Malezija - angleščina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - norethisterone -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

piramal critical care pty ltd - desflurane, quantity: 1 ml/ml - inhalation - excipient ingredients: - piramal desflurane is indicated as an inhalation agent for maintenance of anaesthesia. desflurane is not recommended for mask induction of anaesthesia because of a high incidence of moderate to severe upper airway adverse events.

Evropska unija - angleščina - EMA (European Medicines Agency)

shield tx (uk) limited - ferric maltol - anemia, iron-deficiency - antianemic preparations - feraccru is indicated in adults for the treatment of iron deficiency anaemia (ida) in patients with inflammatory bowel disease (ibd).

Irska - angleščina - HPRA (Health Products Regulatory Authority)

imbat limited - diclofenac sodium; misoprostol - modified-release tablet - 50/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations - non-steroidal anti-inflammatory - it is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis

Irska - angleščina - HPRA (Health Products Regulatory Authority)

imbat limited - misoprostol; diclofenac sodium - modified-release tablet - 75/0.2 milligram(s) - acetic acid derivatives and related substances; diclofenac, combinations - non-steroidal anti-inflammatory - it helps to relieve the pain and swelling of rheumatoid arthritis and osteoarthritis

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - sevoflurane, quantity: 1 ml/ml - inhalation - excipient ingredients: - piramal sevoflurane may be used for induction and maintenance of general anaesthesia in adult and paediatric patients undergoing surgery.

Malta - angleščina - Medicines Authority

piramal critical care limited - sevoflurane - inhalation vapour, liquid - sevoflurane 100 % (w/w) - anesthetics

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

device technologies new zealand - sevoflurane 100%{vol} - volatile liquid for inhalation - 100% v/v - active: sevoflurane 100%{vol} - piramal sevoflurane may be used for the induction and maintenance of general anaesthesia in adult and paediatric patients undergoing surgery.

Izrael - angleščina - Ministry of Health

medison pharma ltd - burosumab - solution for injection - burosumab 10 mg / 1 ml - burosumab - crysvita is indicated for the treatment of x-linked hypophosphatemia (xlh) in adult and paediatric patients 6 months of age and oldertumor-induced osteomalaciacrysvita is indicated for the treatment of fgf23‐related hypophosphatemia in tumor‐induced osteomalacia (tio) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.